SecBot SecBot
144 ·Filed Jun 24, 2026

KYMR

Kymera Therapeutics, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed4mo ago SEC0001628280-26-045290
Form 144, notice of proposed sale of securities
Actionable Insight • Neutral

The filing is a routine VC distribution notice and does not indicate management concern. However, continued selling by Atlas entities could create near-term overhang. Monitor for further Form 144 filings or Form 4 filings to gauge the pace of distribution.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$116.46
T+0 close · Jun 24, 2026 · via day close
Latest settled
+1.11%
T+60 · $117.75
Vs SPY
−2.75%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 25 $116.46entry
  2. T+1 · 5mo ago −7.16%α −6.44% · $108.12
  3. T+5 · 5mo ago −2.53%α −3.96% · $113.51
  4. T+20 · 4mo ago −5.22%α −5.75% · $110.38
  5. T+60 · 8w ago +1.11%α −2.75% · $117.75
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Atlas Venture Fund X, L.P., a venture capital firm and early investor in Kymera Therapeutics, filed a Form 144 notice of intent to sell 118,178 shares of common stock, valued at approximately $11.6 million. This follows a series of large sales by Atlas entities in June 2026, totaling hundreds of thousands of shares, consistent with a venture fund distributing to limited partners. The proposed sale represents a small fraction (0.12%) of Kymera's $9.4B market cap and is not a signal of fundamental deterioration.

Key Facts

  • Atlas Venture Fund X, L.P. filed a Form 144 to sell 118,178 shares of Kymera Therapeutics common stock.
  • Estimated market value of the proposed sale is $11,610,988.50.
  • Shares were acquired in a private placement on March 11, 2020.
  • Atlas entities have sold over 450,000 shares in June 2026 alone, including 243,976 shares on June 22, 2026.
  • The selling entity is a venture capital fund, not an executive insider.

Financial Impact

Proposed sale of 118,178 shares (~$11.6M) represents 0.12% of Kymera's $9.4B market cap.

dilutionownership

Risk Factors

  • Continued selling by Atlas Venture could pressure the stock in the short term.
  • Large insider/affiliate sales may be misinterpreted by the market as a negative signal.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
93% bullish (30 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001628280-26-045290
Document: 0001628280-26-045290-index.html0001628280-26-045290
Document: 0001628280-26-045290.txt0001628280-26-045290

Track record

37 reports on KYMR

Performance horizon

7 of 12 bullish or bearish reports moved the stock their way by T+20. Best: +60.99% at T+60 after the Jun 8, 2026 report. 9 of 14 went positive at some point.

Filters
  1. Nov 2, 202614d ago Institutional Cluster Neutral 3/10 Entry $127.09 Now $125.85 −0.98% settles Dec 2
  2. Oct 29, 202618d ago 8-K Neutral 5/10 No price data
  3. Oct 29, 202618d ago Press Release Bearish 5/10 Entry $122.60 Now $125.85 −2.65% settles Nov 27
  4. Oct 28, 202619d ago Press Release Neutral 5/10 Entry $122.60 Now $125.85 +2.65% settles Nov 27
  5. Oct 27, 202620d ago Institutional Cluster Bullish 4/10 Entry $122.51 Now $125.85 +2.73% settles Nov 25
  6. Oct 27, 202620d ago SC 13G/A Neutral 3/10 Entry $122.51 Now $125.85 +2.73% settles Nov 25
  7. Oct 22, 202625d ago Press Release Neutral 1/10 Entry $110.85 Now $125.85 +13.53% settles Nov 20
  8. Aug 5, 202614w ago 8-K Bullish 6/10 Entry $105.48 to $118.63 Now $125.85 +19.31% ▲ +12.47% +13.07% vs SPY
  9. Jul 7, 202618w ago Insider Cluster Bearish 5/10 Entry $114.16 to $105.48 Now $125.85 −10.24% ▲ +7.60% +10.88% vs SPY
  10. Jul 2, 202619w ago Insider Cluster Bearish 5/10 Entry $114.76 to $100.31 Now $125.85 −9.66% ▲ +12.59% +13.44% vs SPY
Showing 10 of 37

US Market Status

Market Closed · Opens in 8h 28m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 3, 2026